Search Results 1 – 20 of 93
Fostemsavir (Rukobia, FTR)
Pre-exposure Prophylaxis (PrEP) to Prevent HIV During Periconception, Antepartum, and Postpartum Periods
Special Populations
Early (Acute and Recent) HIV Infection
Prenatal Care, Antiretroviral Therapy, and HIV Management in People With Perinatally Acquired HIV Infection
Hepatitis B Virus/HIV Coinfection
Hepatitis C Virus/HIV Coinfection
HIV-2 Infection and Pregnancy
Cabotegravir (CAB)
Recommendations for Use of Antiretroviral Drugs During Pregnancy
Antiretroviral Therapy for People With HIV Who Are Trying to Conceive
Use of Antiretroviral Drugs to Prevent Perinatal HIV Transmission and Improve Health for Pregnant People
Overview
Recommendations for the Use of Antiretroviral Drugs During Pregnancy: Overview
Pregnant People With HIV Who Have Never Received Antiretroviral Drugs (Antiretroviral-Naive)
People With HIV Who Are Taking Antiretroviral Therapy When They Become Pregnant
Pregnant People With HIV Who Have Previously Received Antiretroviral Medications but Are Not Currently on Antiretroviral Medications
Pregnant People Who Have Not Achieved Viral Suppression on Antiretroviral Therapy
Table 6. What to Start: Initial Antiretroviral Regimens During Pregnancy for People Who Are Antiretroviral-Naive
Table 7. Situation-Specific Recommendations for Use of Antiretroviral Drugs in Pregnant People and Nonpregnant People Who Are Trying to Conceive